New mechanisms contributing to hepatic steatosis: glucose, insulin, and lipid signaling
Open Access
- 4 March 2014
- journal article
- other
- Published by Taylor & Francis in Animal Cells and Systems
- Vol. 18 (2) , 77-82
Abstract
Nonalcoholic fatty liver disease (NAFLD) is the most common type of chronic liver disease and can lead to hepatic cirrhosis with liver failure. NAFLD is common in individuals who have obesity, diabetes, dyslipidemia, and/or hypertension. NAFLD comprises a wide spectrum of liver lesions ranging from mild hepatic steatosis to nonalcoholic steatohepatitis (NASH), the most aggressive form. Hepatic steatosis, also called fatty liver, is the hallmark of NAFLD and is defined as excess intrahepatic triglyceride (TG) content (≥5% of liver volume or weight). In some cases, the fat accumulation is associated with steatohepatitis, inflammation, and fibrous change of the liver. Studies on the regulation of de novo fatty acid synthesis have revealed the mechanism leading to hepatic steatosis, mostly emphasizing the roles of transcriptional regulation of enzymes involved in lipid metabolic pathway. Recently, high-fat diet-induced hepatic lipid accumulation has also been associated with hepatocyte uptake of fatty acids from lipolyzed TG in adipose tissue, as well as hepatic TG incorporation. This review discusses a conceptual framework of how hepatic TG accumulation contributes to hepatic steatosis.Keywords
This publication has 36 references indexed in Scilit:
- Insulin stimulation of SREBP-1c processing in transgenic rat hepatocytes requires p70 S6-kinaseProceedings of the National Academy of Sciences, 2012
- Nuclear receptor PPARγ-regulated monoacylglycerol O -acyltransferase 1 (MGAT1) expression is responsible for the lipid accumulation in diet-induced hepatic steatosisProceedings of the National Academy of Sciences, 2012
- The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humansJournal of Clinical Investigation, 2012
- Mechanisms for Insulin Resistance: Common Threads and Missing LinksCell, 2012
- Liver-Specific Expression of Transcriptionally Active SREBP-1c Is Associated with Fatty Liver and Increased Visceral Fat MassPLOS ONE, 2012
- Silencing of Hepatic Fatty Acid Transporter Protein 5 in Vivo Reverses Diet-induced Non-alcoholic Fatty Liver Disease and Improves HyperglycemiaJournal of Biological Chemistry, 2008
- Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered miceJournal of Clinical Investigation, 2008
- Diminished Hepatic Response to Fasting/Refeeding and Liver X Receptor Agonists in Mice with Selective Deficiency of Sterol Regulatory Element-binding Protein-1cJournal of Biological Chemistry, 2002
- Regulation of sterol regulatory-element binding protein 1 gene expression in liver: role of insulin and protein kinase B/cAktBiochemical Journal, 2000
- Steatohepatitis: A tale of two “hits”?Gastroenterology, 1998